Jennifer Furman

Jennifer Furman, PhD, is a highly experienced scientist in the field of biologics discovery and antibody engineering. Currently serving as Principal Scientist at Neurocrine Biosciences since 2023, Jennifer Furman previously held positions as Senior Scientist and Scientist in the Biotherapeutics Discovery team at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2014 to 2023. Earlier, Jennifer Furman completed a postdoctoral research role at Scripps Research from 2011 to 2014. Jennifer Furman earned a Doctor of Philosophy - PhD in Biological Chemistry from the University of Arizona and a Bachelor's degree in Biochemistry from Arizona State University.